Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

MGC Pharmaceuticals receives approval for Phase II trial of CogniCann

On the left is a normal brain, and on the right is a brain of a person with Alzheimer’s disease. Credit: Garrondo (talk/contribs).

Go Top